2016
DOI: 10.1128/mcb.00181-16
|View full text |Cite
|
Sign up to set email alerts
|

Altered Interleukin-10 Signaling in Skeletal Muscle Regulates Obesity-Mediated Inflammation and Insulin Resistance

Abstract: e Skeletal muscle insulin resistance is a major characteristic of obesity and type 2 diabetes. Although obesity-mediated inflammation is causally associated with insulin resistance, the underlying mechanism is unclear. Here, we examined the effects of chronic obesity in mice with muscle-specific overexpression of interleukin-10 (M IL10 ). After 16 weeks of a high-fat diet (HFD), M IL10 mice became markedly obese but showed improved insulin action compared to that of wild-type mice, which was largely due to inc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
37
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 60 publications
(45 citation statements)
references
References 42 publications
5
37
0
1
Order By: Relevance
“…On the other hand, in support of our findings, others found no effect of acute exercise on plasma IL-10 levels in patients with T2D (Korb et al, 2018). Since this myokine has been shown to have a positive effect on skeletal muscle metabolism (Hong et al, 2009;Dagdeviren et al, 2016), perhaps its mechanism of action in response to exercise is autocrine and unrelated to circulating concentrations. This hypothesis would support our findings, as well as those of others, regarding the lack of response to an acute bout of exercise in circulating IL-10.…”
Section: Il-10supporting
confidence: 87%
“…On the other hand, in support of our findings, others found no effect of acute exercise on plasma IL-10 levels in patients with T2D (Korb et al, 2018). Since this myokine has been shown to have a positive effect on skeletal muscle metabolism (Hong et al, 2009;Dagdeviren et al, 2016), perhaps its mechanism of action in response to exercise is autocrine and unrelated to circulating concentrations. This hypothesis would support our findings, as well as those of others, regarding the lack of response to an acute bout of exercise in circulating IL-10.…”
Section: Il-10supporting
confidence: 87%
“…These results are consistent with previous findings that alternatively activated M2polarized macrophages confer protection against dietinduced insulin resistance (3,(10)(11)(12). Moreover, the current results are also consistent with our previous findings that transgenic mice with muscle-specific overexpression of IL-10 were protected from obesitymediated insulin resistance in skeletal muscle (19). Thus, the anti-inflammatory effects of GRP78-deficient macrophages in skeletal muscle may be responsible for the muscle-specific improvement in insulin sensitivity in HFD-fed Lyz-GRP78 2/2 mice.…”
Section: Discussionsupporting
confidence: 94%
“…Protein lysates from BMDM and skeletal muscle (gastrocnemius) samples were prepared for Western blot analysis (19). After blotting, proteins on the membrane were detected with primary Abs against GRP94 (1:1000; Cell Signaling Technology, Danvers, MA, USA), ATF‐6A (1:1000; Santa Cruz Biotechnology, Dallas, TX, USA), ATF‐4 (1:1000; Santa Cruz Biotechnology), phospho‐Akt (Ser 473 ; 1:1000; Cell Signaling Technology), Akt (1:1000; Cell Signaling Technology), GLUT4 (1:1000; Cell Signaling Technology), phospho‐insulin receptor substrate (IRS)‐1 (Tyr 608 ; 1:1000; EMD Millipore, Billerica, MA, USA), and IRS‐1 (1:125; EMD Millipore).…”
Section: Methodsmentioning
confidence: 99%
“…In healthy adults, there is a significant positive association between circulating IL‐10 levels and whole‐body insulin sensitivity (Straczkowski, Kowalska, Nikolajuk, Krukowska, & Gorska, ), and low IL‐10 production capacity is associated with high plasma glucose, high HbA 1c levels, type 2 diabetes, and dyslipidaemia (van Exel et al, ). Genetic alterations in IL‐10 (IL‐10KO), IL‐10 receptor KO (IL‐10RKO), and IL‐10 transgenic (IL‐10Tg) mice have been generated (Cintra et al, ; Dagdeviren et al, ; Hong et al, ; Kowalski et al, ) along with studies by which IL‐10 is administered as a treatment regime (Kim et al, ). Many, but not all, of these models have identified a protective role of IL‐10 against metabolic disease; however, from our analysis, we cannot identify any study involving IL‐10 modulation that has been conducted in female mice, and therefore, the question remains as to whether or not it is of importance in female metabolic processes.…”
Section: Sex Differences In Anti‐inflammatory‐related Mediatorsmentioning
confidence: 99%